NURSING NR 546 ADV MIDTERM STUDY GUIDE WEEK 1-4 (100% GUARANTEED PASS)

Pharmacologic Treatment of Bipolar Disorder - CORRECT ANSWER Lithium Anticonvulsants Second generation antipsychotics Unipolar depression - CORRECT ANSWER major depressive disorder (MDD) one of the most common mental disorders -Approximately 7.1% of adults in the U.S. had episode in last year, prevalence highest (13.1%) among individuals aged 18-25 S/S -depressed mood -loss of interest or pleasure in daily activities -irritability -withdrawal -problems with sleep, eati...

NR546 Antidepressant and Mood Stabilizer Medication Table (2024). Indication  Depression  PMDD  OCD  Panic d/o  GAD  PTSD  Social anxiety d/o Neurotransmitter  Serotonin Target symptoms  Depressed mood  Anxiety  Panic attacks, avoidant behavior, reexperiencing, hyperarousal  Sleep disturbance, insomnia and hypersomnia Half-life 23-45 hour CYP450  Weak inhibitor of CYP450 2D6  Metabolized by CYPf450 3A4 and 2C19  Sexual dy...

QUESTIONS AND ANSWERS

Indication, starting dose, target symptoms, and affected neurotransmitters Half-life (T1/2) CYP450 enzyme Notes/Notable side effects/Precautions SSRIs Citalopram (Celexa) Indication  Depression  PMDD  OCD  Panic d/o  GAD  PTSD  Social anxiety d/o Neurotransmitter  Serotonin Target symptoms  Depressed mood  Anxiety  Panic attacks, avoidant behavior, reexperiencing, hyperarousal  Sleep disturbance, insomnia and hypersomnia Half-life ...

NR 546 Antidepressant and Mood Stabilizer Medication Table (Verified). Escitalopram (Lexapro) Indication  MDD 12+  GAD  Panic d/o  OCD  PTSD  Social anxiety d/o  PMDD Neurotransmitter  Serotonin Half-life 27-32 hours CYP450 Substrate for CYP450 and 3A4 No significant actions on CYP450 enzymes  Sexual dysfunction ED, delayed ejaculation, decreased sexual desire, anorgasmia  Decreased appetite, n/d, constipation, dry mouth  Insomnia and sedati...

Final Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric- Mental Health Nurse Practitioner Final Exam Review | Complete Guide Questions and Verified Answers| 2023/ 2024!! |Chamberlain QUESTION Paroxetine warning Answer: this antidepressant has the highest risk of discontinuation syndrome d/t serotonin transporter inhibition and anticholinergic rebound. If treatment course has lasted 8 weeks, discontinue over 1-2 weeks. QUESTION serotonin syndrome Ans...

Final Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric- Mental Health Nurse Practitioner Final Exam Review | Complete Guide Questions and Verified Answers| 2023/ 2024!! |Chamberlain QUESTION Paroxetine warning Answer: this antidepressant has the highest risk of discontinuation syndrome d/t serotonin transporter inhibition and anticholinergic rebound. If treatment course has lasted 8 weeks, discontinue over 1-2 weeks. QUESTION serotonin syndrome Ans...

Final Exam: NR546/ NR 546 Psychopharmacology for the Psychiatric- Mental Health Nurse Practitioner Final Exam | Graded A Questions and Verified Answers| Latest Update 2023/ 2024 |Chamberlain QUESTION The treatment efficacy of selective serotonin reuptake inhibitors (SSRIs), the most used first -line pharmacological agent is between ______________ with reported remission rates as low as ______ Answer: 48 and 64%, 23.5% QUESTION Is ...